SPONSOR
Queen's University
Total Trials
3
Recruiting
3
Phases
Phase 2, EARLY_Phase 1, Phase 4
Queen's University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Generalized Anxiety Disorder (GAD), Bleeding Disorder, Generalized Anxiety Disorder.
The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Queen's University
How many clinical trials has Queen's University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Queen's University, of which 3 are actively recruiting participants. These trials cover conditions including Generalized Anxiety Disorder (GAD), Bleeding Disorder, Generalized Anxiety Disorder. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Queen's University research focus on?
Queen's University clinical trials span Generalized Anxiety Disorder (GAD), Bleeding Disorder, Generalized Anxiety Disorder. The research pipeline includes Phase 2, EARLY_Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Queen's University clinical trial?
To participate in a Queen's University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Queen's University trials with current recruitment status updated daily.
Clinical Trials by Queen's University
NCT06969170 Phase 2
Recruiting
Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD)
NCT06736158 EARLY_Phase 1
Recruiting
Early Genomic Testing for Inherited Bleeding Disorders
Bleeding Disorder
NCT06218030 Phase 4
Recruiting
Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study
Generalized Anxiety Disorder
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology